Clinical Research Directory
Browse clinical research sites, groups, and studies.
Screening and Secondary Prevention Rheumatic Heart Disease Study
Sponsor: National Institute of Cardiovascular Diseases, Pakistan
Summary
After basic clinical screening including history and physical, Point of care ultrasound will be performed to look at Mitral, Aortic and Tricuspid Valves for regurgitation or stenosis. For patients with confirmed Rheumatic heart disease (RHD), treatment and referral depending on stage of disease. Antibiotic prescription could be shifted to community health workers delivering preventive medications via practical clinical algorithms, diagnostic tools, availability of appropriate antibiotics, and supportive supervision. Patients will have repeat imaging at 2 years and 5 years to look at the outcome of delayed progression of valve disease.
Official title: Screening and Secondary Prevention Rheumatic Heart Disease
Key Details
Gender
All
Age Range
10 Years - 30 Years
Study Type
OBSERVATIONAL
Enrollment
5000
Start Date
2022-09-26
Completion Date
2028-12-31
Last Updated
2023-08-15
Healthy Volunteers
Yes
Conditions
Locations (1)
National Institute of Cardiovascular Diseases (NICVD)
Karachi, Sindh, Pakistan